Search research articles
Contact Us
Filters
Showing results (201-210 of 224) with videos related to
Page
of 23
Sort By:
Cancer Cell
|
October 15, 2014
Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitors
Laura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Blood
|
August 16, 2011
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Antonio Palumbo, Sara Bringhen, Heinz Ludwig, et al.
Lancet (London, England)
|
December 15, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 25, 2020
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
Malin Hultcrantz, Joshua Richter, Cara Rosenbaum, et al.
Blood
|
January 25, 2012
IMWG consensus on maintenance therapy in multiple myeloma
Heinz Ludwig, Brian G M Durie, Philip McCarthy, et al.
Leukemia & Lymphoma
|
September 3, 2010
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma
Monika Engelhardt, Josefina Udi, Martina Kleber, et al.
Nature Communications
|
March 26, 2021
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
Bénedith Oben, Guy Froyen, Kylee H Maclachlan, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
December 13, 2003
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
Brian G M Durie, Robert A Kyle, Andrew Belch, et al.
Blood
|
May 27, 2016
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma
Meletios A Dimopoulos, Antonio Palumbo, Paolo Corradini, et al.
Cell Chemical Biology
|
March 7, 2017
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells
Anthony Tumber, Andrea Nuzzi, Edward S Hookway, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 224) with videos related to
Sort By:
Page
of 23
Cancer Cell
|
October 15, 2014
Cancer-selective targeting of the NF-κB survival pathway with GADD45β/MKK7 inhibitors
Laura Tornatore, Annamaria Sandomenico, Domenico Raimondo, et al.
Blood
|
August 16, 2011
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN)
Antonio Palumbo, Sara Bringhen, Heinz Ludwig, et al.
Lancet (London, England)
|
December 15, 2018
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Meletios A Dimopoulos, Francesca Gay, Fredrik Schjesvold, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 25, 2020
COVID-19 infections and outcomes in patients with multiple myeloma in New York City: a cohort study from five academic centers
Malin Hultcrantz, Joshua Richter, Cara Rosenbaum, et al.
Blood
|
January 25, 2012
IMWG consensus on maintenance therapy in multiple myeloma
Heinz Ludwig, Brian G M Durie, Philip McCarthy, et al.
Leukemia & Lymphoma
|
September 3, 2010
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma
Monika Engelhardt, Josefina Udi, Martina Kleber, et al.
Nature Communications
|
March 26, 2021
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
Bénedith Oben, Guy Froyen, Kylee H Maclachlan, et al.
The Hematology Journal : the Official Journal of the European Haematology Association
|
December 13, 2003
Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation
Brian G M Durie, Robert A Kyle, Andrew Belch, et al.
Blood
|
May 27, 2016
Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma
Meletios A Dimopoulos, Antonio Palumbo, Paolo Corradini, et al.
Cell Chemical Biology
|
March 7, 2017
Potent and Selective KDM5 Inhibitor Stops Cellular Demethylation of H3K4me3 at Transcription Start Sites and Proliferation of MM1S Myeloma Cells
Anthony Tumber, Andrea Nuzzi, Edward S Hookway, et al.
Page
of 23